APA (7th ed.) Citation

Marbaix, S., Marbaix, S., Simoens, S., Clevenbergh, P., Bleyenbergh, P. V., Liberman, K., & Dehenau, D. Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Marbaix, Sophie, Sophie Marbaix, Steven Simoens, Philippe Clevenbergh, Pascal Van Bleyenbergh, Keliane Liberman, and Dimitri Dehenau. Real-world Cost-effectiveness of Nirmatrelvir-ritonavir as Treatment for SARS-CoV-2 Infection in the Belgian Setting with Omicron Variant. Frontiers Media S.A.

MLA (9th ed.) Citation

Marbaix, Sophie, et al. Real-world Cost-effectiveness of Nirmatrelvir-ritonavir as Treatment for SARS-CoV-2 Infection in the Belgian Setting with Omicron Variant. Frontiers Media S.A.